Asahi Kasei Pharma Denmark A/S
Asahi Kasei Pharma Denmark A/S, a subsidiary of the renowned Asahi Kasei Corporation, is headquartered in Denmark (DK) and operates primarily across Europe. Founded in the early 2000s, the company has established itself within the pharmaceutical industry, focusing on innovative healthcare solutions and advanced drug delivery systems. Specialising in the development of biopharmaceuticals and medical devices, Asahi Kasei Pharma Denmark is recognised for its commitment to quality and innovation. Their core products include cutting-edge therapies that address critical health challenges, setting them apart in a competitive market. With a strong emphasis on research and development, Asahi Kasei Pharma Denmark has achieved significant milestones, positioning itself as a leader in the pharmaceutical sector. The company’s dedication to improving patient outcomes underscores its reputation as a trusted partner in healthcare.
DitchCarbon Score
How does Asahi Kasei Pharma Denmark A/S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Asahi Kasei Pharma Denmark A/S's score of 27 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Asahi Kasei Pharma Denmark A/S's reported carbon emissions
Asahi Kasei Pharma Denmark A/S currently does not have available carbon emissions data for recent years, nor do they have specified reduction targets or initiatives documented. This absence of specific emissions figures indicates a potential opportunity for the company to enhance its climate commitments and transparency regarding its environmental impact. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust sustainability practices and set measurable targets for reducing greenhouse gas emissions across all scopes. Asahi Kasei Pharma Denmark A/S may benefit from establishing clear climate goals and reporting frameworks to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Asahi Kasei Pharma Denmark A/S is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
